Skip to main content
. 2023 May 4;54(7):2733–2741. doi: 10.1007/s10803-023-05941-8

Table 1.

Impact on healthcare providers: summary results per child receiving monotherapy (15 years)

England Ireland Italy Spain
Total QALYs Total Costs
(€; 2020)
Total Costs (€; 2020) Total Costs (€; 2020) Total Costs (€; 2020)
Carbamazepine 10.18 27,627 Preferred* 9,658 Preferred* 6,690 Preferred* 7,377 Preferred*
Lamotrigine 10.09 27,686 Dominated 14,552 Dominated 12,385 Dominated 11,013 Dominated
Oxcarbazepine 10.02 30,694 Dominated 12,750 Dominated 8,045 Dominated 9,358 Dominated

*More effective and cost-saving than other alternatives